How Cancer Drug Prices Affect Access

New cancer treatments can offer meaningful advances—but high prices raise questions about affordability and access.

Your gift is doubled through December 31.

Donate Now
Date
November 16, 2026
Time
12:00 PM

New cancer treatments can offer meaningful advances—but increasingly high drug prices raise difficult questions about affordability and access.

NBCC joins Dr. Lee Newcomer and Dr. Daniel Goldstein for a discussion of why cancer drugs launch at the prices they do in the United States, how the current system might better reward meaningful innovation while ensuring access to effective treatments, and what US pricing means for patients and health systems around the world. The conversation will also explore how breast cancer advocates can help push for a more rational, affordable, and accessible system of cancer care.

Speakers

Lee Newcomer, MD
Former Chief Medical Officer, SVP Oncology and Genetics, UnitedHealthcare; Lee N. Newcomer Consulting, LLC
Daniel Goldstein, MD
Professor of Oncology, Internal Medicine, and Health Economics, Tel Aviv University